News & Perspective

Dec 09, 2003

Dec 09, 2003

NIAID funds tularemia research at New York school

(CIDRAP News) – Albany Medical College in Albany, N.Y., has received an $8.3 million federal grant to study pulmonary tularemia, with the main emphasis on developing a vaccine, college officials announced last week.

The grant from the National Institute of Allergy and Infectious Diseases (NIAID) will fund tularemia research at the college for 4½ years, the college said in a news release.

Nov 07, 2003

Nov 07, 2003

Acambis launches clinical trial of West Nile vaccine

(CIDRAP News) – The British biotechnology company Acambis announced yesterday that it has launched the first clinical trial of its vaccine for West Nile virus, called ChimeriVax-West Nile.

The phase 1 trial will involve 60 adult volunteers in Lenexa, Kan., the company said in a news release. The volunteers will receive one of three doses of the West Nile vaccine or a licensed yellow fever vaccine that is being used as a control.

Nov 06, 2003

Nov 06, 2003

Scientists research antidotes to super mousepox virus

(CIDRAP News) – A team of researchers in St. Louis has retooled a mousepox virus so it can defeat a vaccine that normally protects mice—but has also found ways to beat the customized virus, according to the group's leader.

Oct 02, 2003

Oct 02, 2003

NIAID funds further development of new anthrax vaccines

(CIDRAP News) – The federal government awarded two contracts totaling more than $150 million this week for further testing and initial production of new anthrax vaccines designed to be safer and require fewer doses than the existing vaccine.

Oct 01, 2003

Oct 01, 2003

NIAID funds 11 new biodefense labs

(CIDRAP News) – Federal health officials yesterday announced grants to build 11 new biodefense laboratories around the country, including two that will be authorized to study the most dangerous pathogens.

Sep 30, 2003

Sep 30, 2003

NIAID report claims great progress in biodefense research

(CIDRAP News) – Federal health officials yesterday released a 37-page report that they say demonstrates "tremendous progress" in developing countermeasures for bioterrorism through federally funded research since early 2002.

Sep 12, 2003

Sep 12, 2003

Researcher defends view that smallpox shot may give lasting protection

(CIDRAP News) – In response to criticism from smallpox expert Dr. D. A. Henderson, the senior author of a recent study on smallpox immunity has defended his group's conclusion that a single smallpox shot may provide at least some protection for decades or even for life.

Sep 05, 2003

Sep 05, 2003

HHS funds regional biodefense research centers

(CIDRAP News) – The US Department of Health and Human Services yesterday announced $350 million in grants for eight regional centers to lead and coordinate research on defenses against bioterrorism and emerging infectious diseases.

Aug 19, 2003

Aug 19, 2003

West Nile virus vaccine shows promise in monkeys

(CIDRAP News) – As the number of West Nile virus cases continues to climb, the National Institute of Allergy and Infectious Diseases (NIAID) announced that its scientists have created a promising new vaccine against the virus. The vaccine involves a distantly related virus, dengue type 4, in which some proteins have been replaced by corresponding proteins from the West Nile virus.

Aug 07, 2003

Aug 07, 2003

Ebola--improved outbreak containment may be near at hand

(CIDRAP News) – Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) have determined that a single injection of a fast-acting experimental Ebola vaccine confers protection against the disease in monkeys after just 1 month.

Pages

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»